Tianjin CanSino Biotech Inc. is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices. CanSino has established bacterial and cell/viral culture pilot facilities in compliance to the current GMP standard. We can provide service to our clients and partners for clinical trial material production.
View Top Employees from Tianjin CanSino Biotechnology Inc.| Website | http://www.cansinotech.com |
| Ticker | HKG:6185 |
| Revenue | $647.6 million |
| Employees | 68 (68 on RocketReach) |
| Founded | 2009 |
| Address | Biomedical Park 185 401-420 West District Fl 4, Tianjin, Tianjian, CN |
| Phone | +86 400 922 2099 |
| Industry | Biotechnology, Manufacturing General, Biopharma, Manufacturing, Health Care, Science and Engineering, Medical, Medical Device |
| Web Rank | 9 Million |
| Keywords | 康熙诺, Cansino Biologics, Cansino Biologics Inc Ipo, Cansino |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Tianjin CanSino Biotechnology Inc. employee's phone or email?
Tianjin CanSino Biotechnology Inc. Questions
The Tianjin CanSino Biotechnology Inc. annual revenue was $647.6 million in 2024.
武勇慧 President is the Vice President Marketing of Tianjin CanSino Biotechnology Inc..
68 people are employed at Tianjin CanSino Biotechnology Inc..
Tianjin CanSino Biotechnology Inc. is based in Tianjin, Tianjian.
The NAICS codes for Tianjin CanSino Biotechnology Inc. are [32541, 3254, 325, 32].
The SIC codes for Tianjin CanSino Biotechnology Inc. are [28, 283].
Top Tianjin CanSino Biotechnology Inc. Employees
-
21
-
View
Kelvin Zhang
Sr. Director Human Resources at Tianjin CanSino Biotechnology Inc.
Shanghai, Shanghai, China21 -
1
-
1
Related Companies
